Skip to main content

Amanat Acquisition Corp 8-K, filed Oct 26, 2026

Amanat Acquisition Corp. (AMAN)

8-K 2026-10-26 For: 2026-10-25
View Original
Added on October 26, 2026

About this 8-K

Amanat Acquisition Corp filed this 8-K on October 26, 2026, reporting on events of October 25, 2026.

On October 25, 2026, Amanat Acquisition Corp agreed to a business combination with Corxel Pharmaceuticals, based on an implied Corxel equity value of $200,000,000. The combination is expected to close in the first half of 2027, following approvals by Amanat's shareholders and Corxel's sole stockholder. The PIPE Financing carries aggregate purchase commitments of $300 million, subject to reduction mechanisms. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 3.02: Unregistered sale of equity
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits